Teva, a case involving the cardiovascular drug carvedilol, produced a Federal Circuit ruling in 2021 that found generic manufacturers could face induced infringement liability even under a skinny label if their promotional or marketing activities (including Dear Healthcare Provider letters, press releases, and labeling guidance) communicated an intent to encourage use for the protected indication
If you are sensitive to methylfolate supplements, you might be an over-methylator
The role of genetics in endometriosis: insights from recent genome-wide association studies and future directions
The name "KLOW" is a brand designation rather than a pharmacological classification the formulation is also referenced in the research community as the "Wolverine stack" or "Wolverine peptide blend," though those informal nicknames appear nowhere in the published literature
That search led to the 1999 discovery of ghrelin, the natural hormone that activates the same GHS-R1a receptor GHRP-2 uses
COVID-19 and gut immunomodulation